| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/17/2010 | US20100150957 Peptides for active anti-cytokine immunization |
| 06/17/2010 | US20100150951 Plasmodium falciparum antigens inducing protective antibodies |
| 06/17/2010 | US20100150943 Immunogenic compositions for gram positive bacteria |
| 06/17/2010 | US20100150931 Novel receptor for cd40l and uses thereof |
| 06/17/2010 | US20100150924 Regulation of myelination by nectin-like (necl) molecules |
| 06/17/2010 | US20100150923 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 06/17/2010 | US20100150919 Crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 06/17/2010 | US20100150916 huTNFR1 Selective Antagonists |
| 06/17/2010 | US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION |
| 06/17/2010 | US20100150905 Kim-1 antibodies for treatment of th2-mediated conditions |
| 06/17/2010 | US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 06/17/2010 | US20100150881 Compositions and Methods for Use of Scar Tissue in Repair of Weight Bearing Surfaces |
| 06/17/2010 | US20100150877 Osteopontin for the Prediction and Treatment of Cardiovascular Diseases |
| 06/17/2010 | US20100150860 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen, and pharmaceutical composition thereof |
| 06/17/2010 | DE102008060844A1 Antimikrobielle Peptide aus Hydra Antimicrobial peptides from Hydra |
| 06/17/2010 | CA2749558A1 Single-chain antiparallel coiled coil proteins |
| 06/17/2010 | CA2747244A1 Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis |
| 06/17/2010 | CA2747180A1 Use of flt3 ligand for enhancing immune responses in rna immunization |
| 06/17/2010 | CA2746256A1 Methods and compositions for specific modulation of mcl-1 |
| 06/17/2010 | CA2746103A1 Screening method for identifying genes involved in plant cell cycle |
| 06/17/2010 | CA2745849A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer |
| 06/17/2010 | CA2745492A1 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 06/17/2010 | CA2688804A1 Polycistronic vector for human induced pluripotent stem cell production |
| 06/16/2010 | EP2196804A1 Labeled peptide having activity of binding to immunoglobulin and/or immunoglobulin complex and method of detecting or assaying immunoglobulin by using the peptide |
| 06/16/2010 | EP2196536A1 Methods for production of proteins |
| 06/16/2010 | EP2196477A1 Modified recombinant human endostatin and its application |
| 06/16/2010 | EP2196475A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 06/16/2010 | EP2196474A2 Therapeutic targets in cancer |
| 06/16/2010 | EP2196473A1 Mycobacterial antigens expressed during latency |
| 06/16/2010 | EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 06/16/2010 | EP2196217A1 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/16/2010 | EP2196215A1 Method for making an immunogenic composition with Hoc fusion proteins and Soc fusion proteins |
| 06/16/2010 | EP2196214A1 Method for making an immunogenic composition with Hoc fusion proteins and/or Soc fusion proteins |
| 06/16/2010 | EP2196210A1 A method for reducing the likelihood of preeclampsia in a subject in need thereof |
| 06/16/2010 | EP2196193A1 Hydrogels suitable for use in polyp removal |
| 06/16/2010 | EP2195439A1 Use of aav replication machinery for improved protein production |
| 06/16/2010 | EP2195437A2 Polypeptides, such as lipases, capable of altering the seed storage content in transgenic plants. |
| 06/16/2010 | EP2195436A2 Pathogen control genes and methods of use in plants |
| 06/16/2010 | EP2195435A1 Trichoderma promoter |
| 06/16/2010 | EP2195431A1 Methods for increasing protein titers |
| 06/16/2010 | EP2195426A2 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 06/16/2010 | EP2195423A1 Glucoamylase variants with altered properties |
| 06/16/2010 | EP2195422A1 Glucoamylase variants |
| 06/16/2010 | EP2195347A1 Method for treating and diagnosing hematologic malignancies |
| 06/16/2010 | EP2195340A2 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| 06/16/2010 | EP2195339A2 A process for producing hepcidin |
| 06/16/2010 | EP2195338A1 N-terminal modified interferon-alpha |
| 06/16/2010 | EP2195337A1 Trimeric il-1ra |
| 06/16/2010 | EP2195335A1 Diagnostic agent |
| 06/16/2010 | EP2195334A1 Ligand binding domains of nuclear receptors in controllable form and methods involving the same |
| 06/16/2010 | EP2195333A1 Hsp70-based treatment for autoimmune diseases |
| 06/16/2010 | EP2195332A1 Modulators of hypersensitivity reactions |
| 06/16/2010 | EP2195028A2 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| 06/16/2010 | EP2195013A1 Therapeutic use of a growth factor, metrnl |
| 06/16/2010 | EP1645566B1 Analogs of parathyroid hormone |
| 06/16/2010 | EP1627917B1 NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO |
| 06/16/2010 | EP1622921B1 Variants of beta-glucosidases |
| 06/16/2010 | EP1611153B1 Antitumor effect of mutant bik |
| 06/16/2010 | EP1587816B1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 06/16/2010 | EP1560594B1 Antigenic compositions for immunization of non-human mammals against streptococcus equi |
| 06/16/2010 | EP1234024B2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/16/2010 | CN1924016B Human tissue factor pathway inhibitory factor mutation gene m2TFPI, recombination carrier and recombination microzyme including the same |
| 06/16/2010 | CN1911961B Application of paddy rice flower meristem control gene EG1 |
| 06/16/2010 | CN1894276B HCV NS3-NS4A protease resistance mutants |
| 06/16/2010 | CN1875029B Expression in filamentous fungi of protease inhibitors and variants thereof |
| 06/16/2010 | CN1867582B Process for preparing an alpha-1-antitrypsin solution |
| 06/16/2010 | CN1812997B Pharmaceutical composition outside stomach intestine containing somatostatin analogue |
| 06/16/2010 | CN1795203B Method for screening inhibitors of the gamma-secretase |
| 06/16/2010 | CN1768140B A high-troughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 06/16/2010 | CN1634981B A group of antibiotic peptides, method for preparation and use thereof |
| 06/16/2010 | CN1608129B Alkaline protease from bacillus sp. (DSM 14392) and uses thereof |
| 06/16/2010 | CN1526732B Process for producing high pureness albumin solution |
| 06/16/2010 | CN1518558B Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament |
| 06/16/2010 | CN1500095B Polymer conjugates of neublastin and methods of using ssame |
| 06/16/2010 | CN1487996B Transgenic transchromosomal rodents for making human antibodies |
| 06/16/2010 | CN1406249B Enhancing the circulating half-life of antibody-based fusion proteins |
| 06/16/2010 | CN1162978B Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 06/16/2010 | CN101743474A Methods for detecting cardiac damage |
| 06/16/2010 | CN101743470A copolymer assay |
| 06/16/2010 | CN101743314A Transgenic plants with increased stress tolerance and yield |
| 06/16/2010 | CN101743309A Modified factor vii polypetides and uses thereof |
| 06/16/2010 | CN101743253A crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 06/16/2010 | CN101743252A protease stabilized, pegylated insulin analogues |
| 06/16/2010 | CN101743251A Peptides with anitfungal activity |
| 06/16/2010 | CN101743250A Signaling peptides |
| 06/16/2010 | CN101743249A Fusion molecules and IL-15 variants |
| 06/16/2010 | CN101743018A Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |
| 06/16/2010 | CN101736067A Lactoalbumin antihypertensive peptide, preparation method and application thereof |
| 06/16/2010 | CN101736062A Method for preparing recombinant porcine alpha interferon standard substance |
| 06/16/2010 | CN101736045A Method for continuously extracting functional components of chlorella vulgaris |
| 06/16/2010 | CN101736029A Method for producing human insulin-like growth factor-1 by vegetable oil ribosomal protein expression system |
| 06/16/2010 | CN101736017A Classical swine fever virus E2 subunit vaccine and preparation thereof |
| 06/16/2010 | CN101736012A Stress resistance ERF transcription factor gene derived from Brassica napus |
| 06/16/2010 | CN101736011A Antifreeze CBF transcription factor gene of brassica napus |
| 06/16/2010 | CN101736010A Stress resistance NAC transcription factor gene derived from loosehead Chinese cabbage |
| 06/16/2010 | CN101736009A Method for producing human interleukin 6 by high-density fermentation |
| 06/16/2010 | CN101736008A Method for preparing genetic engineering N-acetylated thymosin alpha1 |
| 06/16/2010 | CN101736006A Method for recombinant expression of soluble transcription mediator complex Med23 subunit |
| 06/16/2010 | CN101736005A Preparation method of human cytochrome c |
| 06/16/2010 | CN101736004A Method for preparing high-purity amyloid polypeptide Abeta (1-40) |